Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
23andMe logo

23andMe

Recent Finacing

Series A

Recent Raise

$250M

23andMe operates direct-to-consumer genetic testing, selling at-home saliva kits and providing ancestry and health reports, while running an opt-in research platform and therapeutics collaborations using de-identified genetic data.

Founded 2006
California, United States
501-1K
Publicly Traded
23andme.com

Highlights

Focus Areas

Biotechnology
Genetics
Life Science

Recent Investors

Fidelity Management & Research Company logo
Casdin Capital logo
Altimeter Capital logo
Sequoia Capital logo
New Enterprise Associates logo
MPM Capital logo
GSK logo
Foresite Capital logo
E
W
NewView Capital logo
Google Ventures logo

Financials

$3.5B

Valuation as of 02/04/2021

$1.1B

Total Raised

10

Funding rounds

17

Investors


Team

Upgrade to view the team

See the team members at 23andMe.